Yatsen Holding Limited (YSG) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance, with significant revenue and gross profit growth, improved margins, and reduced losses. The Q&A section reveals optimism about profitability in Q4 and sustained growth through R&D and marketing optimization. Despite competition, the company's strategy to focus on high-end brands and innovation is promising. The lack of detailed guidance on expenses is a minor concern, but overall, the positive financial results and optimistic outlook suggest a positive stock price movement.
Key Financial Performance
Total Net Revenues RMB 998.4 million, a 47.5% increase year-over-year. The increase was primarily due to an 83.2% year-over-year increase in net revenues from skincare brands and a 25.2% year-over-year increase in revenue from color cosmetics brands.
Gross Profit RMB 780.5 million, a 51.9% increase year-over-year. The increase was primarily driven by an increase in sales of higher gross margin products.
Gross Margin 78.2%, up from 75.9% in the prior year period. The increase was primarily driven by an increase in sales of higher gross margin products.
Total Operating Expenses RMB 864.1 million, a 31.9% increase year-over-year. As a percentage of total net revenues, it decreased to 86.5% from 96.8% in the prior year period.
Fulfillment Expenses RMB 61.8 million, up from RMB 50.4 million in the prior year period. As a percentage of total net revenues, it decreased to 6.2% from 7.4%, primarily driven by fulfillment cost optimization and the leveraging effect of higher total net revenues.
Selling and Marketing Expenses RMB 682.3 million, up from RMB 494.4 million in the prior year period. As a percentage of total net revenues, it decreased to 68.3% from 73%, driven by a higher skincare mix and more disciplined spending across channels.
General and Administrative Expenses RMB 80.2 million, down from RMB 85 million in the prior year period. As a percentage of total net revenues, it decreased to 8% from 12.6%, primarily driven by lower share-based compensation expenses and the leveraging effect of higher total net revenues.
Research and Development Expenses RMB 39.8 million, up from RMB 25.3 million in the prior year period. As a percentage of total net revenues, it increased to 4% from 3.7%, primarily driven by higher payroll expenses due to an increase in R&D headcount.
Loss from Operations RMB 83.6 million, down from RMB 141.3 million in the prior year period. Operating loss margin improved to 8.4% from 20.9%.
Net Loss RMB 70.4 million, down from RMB 121.1 million in the prior year period. Net loss margin improved to 7% from 17.9%.
Non-GAAP Net Loss RMB 51.5 million, down from RMB 76.6 million in the prior year period. Non-GAAP net loss margin improved to 5.2% from 11.3%.
Cash, Restricted Cash, and Short-term Investments RMB 1.16 billion as of September 30, 2025, down from RMB 1.36 billion as of December 31, 2024.
Net Cash Used in Operating Activities RMB 126.8 million, down from RMB 175.9 million in the prior year period. The decrease was primarily due to working capital movements, including inventory positioning and receivables timing ahead of Double 11.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Skincare brands growth: Skincare brands grew by 83.2% year-over-year, reaching 49.2% of total revenue. Galénic's hero serum series performed well, with the newly launched VB serum becoming a best-seller. DR. WU launched its first anti-aging product in the U.K., gaining traction with innovative formulations. Perfect Diary focused on hero product quality, with its space makeup category exceeding 40% of total sales.
Market expansion: DR. WU entered the U.K. market with its first anti-aging product, leveraging clinical expertise. Perfect Diary achieved #1 ranking among makeup brands on WeChat video channel, reflecting strengthened competitiveness.
Revenue growth: Total net revenues increased by 47.5% year-over-year to RMB 998.4 million, driven by skincare and color cosmetics brands.
Profitability improvement: Net loss margin improved from 17.9% to 7% year-over-year due to gross margin optimization and disciplined resource allocation.
R&D and innovation: Participated in IFCC Congress for the fourth consecutive year, with 11 papers shortlisted. Focused on advancing scientific research to support hero product development and long-term competitiveness.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The beauty market in China is showing signs of recovery, but there is no guarantee that this trend will continue, which could impact future revenue growth.
Profitability Challenges: Despite narrowing net losses, the company is still operating at a loss, with a net loss margin of 7% for the quarter. Achieving profitability remains a challenge.
High Operating Expenses: Total operating expenses remain high at 86.5% of total net revenues, which could hinder profitability if not managed effectively.
Seasonal Marketing Investments: The company has made significant upfront investments for the Double 11 shopping season, which elevate short-term selling and marketing expenses and may not yield the expected long-term benefits.
Cash Flow Concerns: Net cash used in operating activities was RMB 126.8 million for the quarter, indicating ongoing cash flow challenges.
Regulatory Risks: Forward-looking statements are subject to risks and uncertainties, some of which are beyond the company's control, potentially impacting future performance.
Supply Chain and Inventory Management: Working capital movements, including inventory positioning ahead of Double 11, could pose risks if inventory efficiency is not optimized.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Profitability Progression: The company aims to continue progressing toward profitability in a disciplined and sustainable manner. This will be driven by a higher income mix, ongoing gross margin optimization, and greater marketing efficiency.
Investment in Innovation: Yatsen plans to continue investing in innovation and hero products while maintaining a balance between growth and profitability.
Revenue Projections for Q4 2025: The company expects total net revenues for the fourth quarter of 2025 to be between RMB 1.32 billion and RMB 1.49 billion, representing a year-over-year increase of approximately 15% to 30%.
Operational Improvements: Yatsen anticipates improved operating cash flow in the fourth quarter as investments convert into revenue and inventory efficiency and marketing ROI are optimized.
Brand and Product Development: The company will prioritize investments that strengthen core brands and innovation capabilities, aiming for long-term shareholder value creation.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How did the company perform during the Double 11 festival, and what changes in competition from foreign high-end brands were observed?
A:The company's performance during the Double 11 festival was generally in line with expectations, with some brands exceeding expectations. Newly launched products gained strong momentum, contributing to future growth. The company observed significant competition from foreign high-end brands, which engaged in deep price cuts. However, the company's high-end brand maintained strong momentum by balancing price promotions and focusing on new SKUs.
Q:What is the company's outlook on profitability for Q4 and the next year?
A:The company is on track to achieve profitability in Q4 and is focused on balancing growth with profitability as a long-term goal.
Q:What are the key drivers for the company's skincare business growth, and how will it sustain this growth in the future?
A:Key drivers include R&D for product innovation, expansion of the skincare portfolio, increasing brand awareness, and launching new products in key channels. Sustained growth will come from optimizing product and channel mix, improving ROI on marketing expenses, and leveraging branding expenses as revenue scales grow.
Q:How does the company plan to continuously improve profitability?
A:The company plans to improve profitability through product and channel mix optimization, better ROI on marketing expenses, and leveraging branding expenses as brands reach optimized revenue thresholds.
Q:What are the company's expected future expenses, and how does it view competition in the online channel?
A:The company expects stable G&A expenses with operational leverage as revenue grows. It will continue investing in R&D and branding to build brand equity. Regarding online competition, the company focuses on R&D, brand building, product innovation, and operational efficiency to achieve sustainable growth.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the expected future expenses, offering only general statements about stable G&A expenses and investments in R&D and branding. Additionally, their response to online competition was broad, emphasizing general strategies without addressing specific competitive challenges or actions.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ABC level
AI algorithm
AVA serum
Acid category
Association brand
BioFace Essence
Blurring Powder
China DR
China sign
Chinese Nongovernment
Committee Chinese
Congress paper
DR Mandelic
IFCC
brand commitment
brand progress
capability
commerce platform
competitiveness
core
hero product
highlight
makeup
momentum
portfolio
recovery
resource allocation
series
skin care
technology
translation
value
YSG Transcript
Yatsen Holding Limited (YSG) Q1 2026 Earnings Call Transcript
Neutral5-26
Yatsen Holding Limited (YSG) Q4 2025 Earnings Call Transcript
Unknown3-2
The company shows strong revenue growth and improved profitability, yet faces challenges with high marketing expenses and reliance on skincare. Despite an optimistic guidance, the Q&A reveals no new partnerships or groundbreaking strategies. With no market cap data, the impact is uncertain, but the mixed signals and existing risks suggest a neutral stock price movement.
Yatsen Holding Limited (YSG) Q3 2025 Earnings Call Transcript
Positive11-17
The earnings call highlights strong financial performance, with significant revenue and gross profit growth, improved margins, and reduced losses. The Q&A section reveals optimism about profitability in Q4 and sustained growth through R&D and marketing optimization. Despite competition, the company's strategy to focus on high-end brands and innovation is promising. The lack of detailed guidance on expenses is a minor concern, but overall, the positive financial results and optimistic outlook suggest a positive stock price movement.
Yatsen Holding Limited (YSG) Q2 2025 Earnings Call Transcript
Positive8-21
The earnings call reveals strong financial performance with increased gross margin, reduced operating losses, and a shift to non-GAAP net income. The strategic focus on high-margin skincare and R&D investments, alongside a share repurchase program, indicates confidence in future growth. Positive Q3 guidance for skincare and improved profitability strategies further bolster the outlook. Despite increased competition, the company's robust R&D capabilities and strategic initiatives suggest a positive trajectory. The Q&A section supports this with no significant concerns raised by analysts, reinforcing the positive sentiment.
YSG Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
